Genesis 2026

, a special case-study into the story behind 

. Giovanni is a co‑founder of Aptadir, a biotech company developing innovative RNA‑based targeted therapeutics designed to address diseases with high unmet medical needs. Drawing on his experience in both scientific research and startup creation, he has played a central role in moving the company from concept to operational growth.

In this session, Giovanni will walk through the key milestones and decisions that shaped Aptadir’s path. The participants will gain practical insights into the challenges and opportunities of launching a life sciences venture, learning directly from an entrepreneur who has navigated the transition from research idea to a functioning biotech startup.

Genesis 2026 - L07: From Theory to Practice: Aptadir Therapeutics - Giovanni Amabile